The US Senate passed the Promise to Address Comprehensive Toxics (PACT) Act on August 2, 2022. The PACT healthcare bill is a positive step toward assisting the 3.5 million veterans affected by exposure to toxins during military service. The debate surrounding the PACT legislation drew attention to a stark fact: too many of America’s veterans live with ill health. In 2020, the Veterans Administration National Center for PTSD conducted a…READ MORE
The Latest
Tribal Diagnostics Announces Availability of Personalized Alzheimer’s and Dementia Care Plans Via Partnership with uMETHOD Health
October 17, 2023
OKLAHOMA CITY, Oct. 17, 2023 -- Tribal Diagnostics, a high-complexity diagnostics laboratory, has announced availability of the RestoreU™ Dementia Panel throughout Texas and Oklahoma. RestoreU is a risk assessment and care plan service created by uMETHOD Health, a health technology company specializing in precision medicine for chronic diseases, to help physicians close care gaps for patients with cognitive decline. RestoreU's Assistive AI improves care for individuals suffering from chronic diseases like Alzheimer's with multiple underlying medical causes. It creates…READ MORE
uMETHOD Health, a precision-medicine software company based in the Research Triangle of North Carolina, is pleased to announce enhancements to their customized care plans that streamline the process for administering cognitive care. The new features consist of eight checklist-style “compliance elements.” These components assist physicians in completing the required service elements for the Cognitive Assessment and Care Plan (CACP) developed by the U.S. Centers for Medicare and Medicaid Services (CMS).…READ MORE
Recent News of Bruce Willis’s Frontotemporal Dementia Diagnosis Raises Questions About Available Treatments
March 6, 2023
Frontotemporal Dementia (FTD) is a neurodegenerative disease that affects two brain structures: the frontal lobes and the temporal lobes. The location of damage is distinct from that of Alzheimer’s Disease (AD), which is characterized by the degeneration of the brain structure known as the hippocampus. For each of these conditions, neurodegeneration can be readily quantified by the amount of shrinkage (loss of tissue) in these structures, which can be observed…READ MORE
Today’s standard of care for complex diseases like Alzheimer’s Disease (AD) and related dementias fails to meet the needs of an aging patient population. It falls short of providing adequate guidance for clinicians who bear the burden of this care gap. Complex diseases proceed from many contributing factors -- medical, genetic, and environmental -- that vary widely from person to person. Untangling the web of factors that contribute to neurodegeneration can…READ MORE
Being Patient talks to Dr. John Walker, who founded uMETHOD Health, the first company that is using precision medicine and AI to help treat Alzheimer’s, about how technology could diagnose and prevent cognitive decline. To view the video, click here.…READ MORE